CTX211
DEAD

Serial Number

98347437

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Jan 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CTX211 Trademark

Serial Number: 98347437

CTX211 is a trademark filed by CRISPR Therapeutics AG on January 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

January 8, 2024

Registration Date

Not Registered

Goods & Services

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 21, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 21, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 5, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 5, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2024 CNRT
ASSIGNED TO EXAMINER
May 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2024 NWOS
NEW APPLICATION ENTERED
Jan 8, 2024 NWAP